Kalo
Abdel Magid Kalo, Beirut LB
Patent application number | Description | Published |
---|---|---|
20100102007 | Process for Treatment of Sewage Waste Water - This is a reliable cost-effective adsorption based method for removing the dissolved and suspended organic matter by adding a natural “flocculent sorption particles” which is (Sodium, Calcium, Alumino silicate hydrated), and ferric Chloride, using a mixing tank. Heavy Macro-particles are formed that can be gravity separated and easily dewatered. The supernatant is first treated by OZONE to reduce the remaining organic pollutants and kill the bacteria, then filtered through a single layer of filter media. The suspended solids are mechanically strained down to 3-5 microns. | 04-29-2010 |
Arie Kalo, Ness-Ziona IL
Patent application number | Description | Published |
---|---|---|
20110096633 | PORTABLE DIVER APPARATUS, COMPRISING A PORTABLE COMPUTING DEVICE AND AN ADD ON DIVER DEVICE - A portable diving apparatus, which comprises: (a) a water proof casing which comprises an external key pad; (b) a portable computing device within said water proof casing, said portable computing device comprises a diving module; (c) a pressure sensor which is mounted at least partially outside said water proof casing; (d) an adaptor within said water proof casing for receiving key pad entries from said key pad by means of first cable, and pressure indications from said pressure sensor by means of third cable, and for converting said key pad entries and said pressure indications to key pad data and pressure data respectively in a standard communication protocol, and transferring said data in said (wired or wireless) standard communication protocol into said portable computing device, wherein at least said pressure indications are processed by said diving module of said portable computing device and displayed as diver information on a display of said portable computing device. | 04-28-2011 |
20110102178 | INTRUSION DETECTION SYSTEM AND ITS SENSORS - An intrusion detection system, that comprises a multi sensors array deployable along a physical barrier means and linkable to it in a manner that enables sensing various phenomena (one or more), typically take place when an attempted intrusion act occurs through the physical barrier means, and generation of an indication when such a phenomenon is sensed, characterized by that, that at least in one of the sensors there is installed a processing component that belongs and is specifically allocated to the sensor and enables local analyzing of the sensed phenomena within said sensor. | 05-05-2011 |
Hussein Kalo, Bayreuth DE
Patent application number | Description | Published |
---|---|---|
20110204286 | SYNTHETIC PHYLLOSILICATES NOT CAPABLE OF SWELLING FOR POLYMER PHYLLOSILICATE (NANO)COMPOSITES - The present invention relates to a process for the production of non-swellable phyllosilicate tactoids, comprising | 08-25-2011 |
20130035432 | PROCESS FOR THE PRODUCTION OF PHYLLOSILICATE DISCS HAVING A HIGH ASPECT RATIO - The present invention relates to a process for the production of phyllosilicate platelets having a high aspect ratio, to a phyllosilicate platelet obtainable by the process according to the invention, to the use of phyllosilicate platelets according to the invention in the production of a composite material, of a flameproof barrier or of a diffusion harrier, and to a composite material comprising or obtainable using phyllosilicate platelets according to the invention. | 02-07-2013 |
Mattew Kalo, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090305967 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA - The present invention provides conjugates between Factor VII or Factor VIIa peptides and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention. | 12-10-2009 |
Matthew Kalo, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100113743 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA - The present invention provides conjugates between Factor VII or Factor VIIa peptides and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention. | 05-06-2010 |
20100330645 | ONE POT DESIALYLATION AND GLYCOPEGYLATION OF THERAPEUTIC PEPTIDES - The present invention provides conjugates between peptides and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention. | 12-30-2010 |
20130137157 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA - The present invention provides conjugates between Factor VII or Factor VIIa peptides and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention. | 05-30-2013 |